Medical Marijuana, Inc., the first publicly traded cannabis company in the United States, today announced that its major investment company AXIM Biotechnologies, Inc. has entered into a Clinical Study Agreement (CSA) with the University of British Columbia in Canada to begin a clinical trial with its CanChew Plus® cannabidiol (CBD) chewing gum product to treat drug-induced psychosis in adult patients. The University will work with Health…
Treatment for acute myeloid leukemia (AML), one of the most aggressive forms of leukemia, involves chemotherapy drugs that many patients find difficult to tolerate and long-term survival is low. New treatments are desperately needed. Dr. Keith Humphries and his program project team based at the BC Cancer Agency in Vancouver, BC are developing cell models of leukemia that could drastically…
Each year in Canada, more than 15,500 people will be diagnosed with epilepsy – 55% of those before the age of ten. In 50-60% of the cases, the cause is unknown. Refractory epilepsy – described as that which cannot be controlled with two or more medications – is especially dangerous, because uncontrolled seizures interfere with normal brain growth, and can…
Achieve Life Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for cytisine, an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe for more than 15 years. The company is now authorized to proceed with clinical development of cytisine in the U.S. Cytisine is a plant-based…
bioLytical Laboratories, a world leader in rapid infectious disease tests, is pleased to announce the launch of the INSTI® HIV Self Test in pharmacies across the Netherlands. With a single drop of blood, the INSTI HIV Self Test is more than 99% accurate and provides a result instantly. With other home tests, individuals must wait 15 to 20 minutes (after the test is conducted) for a…
At MSFHR we partner to grow BC research talent in two main ways: inviting organizations to co-fund MSFHR awards, and contributing match funding for BC researchers applying for national and international projects that address our province’s health system priorities. This match funding enables BC researchers to participate in national and international research, build connections and apply their learnings to the BC…
Congratulations to Dr. Manish Sadarangani on his recent appointment as the Sauder Chair in Pediatric Infectious Diseases at the University of British Columbia. Funded by a donation from the Sauder Family, the Chair supports research to improve the prevention, diagnosis and treatment of childhood infectious diseases. When it comes to saving the lives of kids with serious infections, Dr. Sadarangani believes “the…
Aequus Pharmaceuticals Inc., a specialty life sciences company focused on providing patients with differentiated and enhanced delivery systems for existing and approved drugs, and Scientus Pharma Inc., a biopharmaceutical company focused on R&D and product commercialization for extracts and formulations related to medical cannabinoids and their derivatives, announced today that they have signed a non-binding term sheet on a collaboration…
Yes, you read that right: Getting dirty may reduce your risk of depression. But before you start rolling in the mud or even worse, eating it, let’s take a step back. The hygiene hypothesis has been bandied about for ages. In a nutshell, it suggests that we are too clean, which is why we get sick. Early childhood is the time when…
The use of medication in modern medicine has revolutionized healthcare and made a significant impact on patient longevity and quality of life. Unfortunately, many medications can also cause unintended side effects – also known as adverse drug reactions (ADRs). In an effort to reduce severe ADRs in Canada, researchers at the University of British Columbia (UBC) and the BC Children’s…